| Literature DB >> 32282038 |
John McAteer1, Inci Yildirim1,2,3, Ann Chahroudi1,3.
Abstract
Since the COVID-19 pandemic first hit Wuhan, China, in December 2019, scientists have been racing to develop and test novel vaccines to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The speed of scientific discovery related to COVID-19 is unprecedented. With several vaccine candidates already being tested in clinical trials, we pose the question: what will the vaccine hesitant do in the face of this pandemic?Entities:
Keywords: COVID-19; antivax; immunization; vaccine hesitancy
Mesh:
Substances:
Year: 2020 PMID: 32282038 PMCID: PMC7184475 DOI: 10.1093/cid/ciaa433
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079